CFLAR and breast cancer: In addition, when we assessed the capacity of ECM-detachment to alter c-FLIPL levels in a range of breast cancer lines representing distinct molecular subtypes (Supplemental Fig. 2A), the ability of ECM-detachment to cause c-FLIPL upregulation was largely not observed.